Covalon Technologies (Covalon) has established a distribution channel for its products into Mexico where it will target advanced wound care and infection management markets.
Through a distribution arrangement with a partner company in Mexico, Covalon will be distributing Covalon-branded products, including Covalon’s CovaWound and ColActive Plus advanced wound care lines and Covalon’s IV Clear™ and SurgiClear infection management products into Mexico.
“Mexico is a key market for Covalon. It is one of the largest and most sophisticated healthcare markets in Latin America. Our success in establishing this key distribution channel in Mexico will help drive increased sales of our products into other Latin American countries,” said Brian Pedlar, chief executive officer at Covalon.
“We are starting to implement in the vast Latin American market, the exact same strategy we have successfully implemented in the Middle East. Interestingly, the large contract awards Covalon recently won in the highly competitive Saudi Arabian market are definitely being noticed by medical thought-leaders in Latin America.”
John Hands, executive vice president at Covalon, said: “As we have consistently stated, Mexico is key to accelerating our business as Covalon enters the vast Latin American market. Covalon's products are uniquely positioned to address many of the product gaps currently found in the Latin American medical market, especially when one considers the explosion of diabetic-related wounds in the region.”
Covalon Technologies, US, Healthcare, Insurance, Risk management, Wound care, Technology, IT